Parkman Healthcare Partners LLC - 06 Oct 2025 Form 4 Insider Report for SPRUCE BIOSCIENCES, INC. (SPRB)

Role
10%+ Owner
Signature
Parkman Healthcare Partners LLC, By: /s/ Gregory Martinez, Chief Investment Officer
Issuer symbol
SPRB
Transactions as of
06 Oct 2025
Net transactions value
-$335
Form type
4
Filing time
15 Oct 2025, 16:32:43 UTC
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Parkman Healthcare Partners LLC 10%+ Owner 700 CANAL STREET, STAMFORD Parkman Healthcare Partners LLC, By: /s/ Gregory Martinez, Chief Investment Officer 15 Oct 2025 0001777015
Martinez Gregory 10%+ Owner 700 CANAL STREET, STAMFORD /s/ Gregory Martinez 15 Oct 2025 0002091748

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRB Common Stock, $0.001 par value per share Purchase $4,585 +256 +24% $17.91 1,307 06 Oct 2025 See footnote F1, F2
transaction SPRB Common Stock, $0.001 par value per share Sale $4,484 -232 -18% $19.33 1,075 06 Oct 2025 See footnote F2, F3
transaction SPRB Common Stock, $0.001 par value per share Sale $436 -25 -2.3% $17.46 1,050 06 Oct 2025 See footnote F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Parkman Healthcare Partners LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $17.55 to $18. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F2 The amount reported represents the Reporting Persons' pecuniary interest held through an investment in private funds. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $19.125 to $19.63. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $17.44 to $17.56. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

As previously disclosed in Parkman Healthcare Partners LLC's Form 4 with respect to the Issuer filed on October 8, 2025, these securities are also indirectly beneficially owned by Gregory Martinez.